Metraipolis › archive › dc_ac7deeb97ec3
Factors influencing oncologists' decisions for germline BRCA testing and adjuvant therapy selection in HER2-negative early breast cancer — Europe PMC PMID:42755752
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42755752
- DOI
- 10.3389/fonc.2026.1854965
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T03:53:03.235Z
- SHA-256 of the archived text
95acb9b1a07d9068d55b46f8b6b290148efad1c0816847ac46741d5fcee9a401- Stable URL of this page
https://metraipolis.com/documento/dc_ac7deeb97ec3
How to cite
Factors influencing oncologists' decisions for germline BRCA testing and adjuvant therapy selection in HER2-negative early breast cancer — Europe PMC PMID:42755752 — Europe PMC (en), https://europepmc.org/article/MED/42755752 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ac7deeb97ec3 (Metraipolis archive dc_ac7deeb97ec3, sha256 95acb9b1a07d9068d55b46f8b6b290148efad1c0816847ac46741d5fcee9a401)
BibTeX
@misc{dcac7deeb97ec3,
title = {Factors influencing oncologists' decisions for germline BRCA testing and adjuvant therapy selection in HER2-negative early breast cancer — Europe PMC PMID:42755752},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42755752},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ac7deeb97ec3; sha256 95acb9b1a07d9068d55b46f8b6b290148efad1c0816847ac46741d5fcee9a401},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755752. Agents can read the archived copy with the MCP tool read_document.